Literature DB >> 9276615

Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators.

M L Rose1, D R Germolec, R Schoonhoven, R G Thurman.   

Abstract

WY-14,643 [4-chloro-6-(2,3-xylidino)pyrimidinylthio-acetic acid] is a well-known non-genotoxic carcinogen and peroxisome proliferator that causes liver cancer in rodents by unknown mechanisms. Its ability to sustain elevated rates of hepatocyte DNA synthesis is most likely pivotal in the ultimate development of tumors. The source of this mitogenic stimulus following treatment of rats with WY-14,643 has been hypothesized to be Kupffer cells, the resident hepatic macrophages, since they are activated by peroxisome proliferators in vivo. Therefore, these studies were designed to determine if Kupffer cells are causally responsible for WY-14 643-induced increases in hepatocyte DNA synthesis in vivo. WY-14,643 (100 mg/kg) increased DNA synthesis 8-fold 24 h after treatment; however, inactivation of Kupffer cells with methyl palmitate, a nonhydrolyzable fatty acid ester and known Kupffer cell inhibitor, completely prevented the mitogenic effect of WY-14,643. On the other hand, the ability of WY-14,643 to induce peroxisomes was not affected by methyl palmitate. These data demonstrate that induction of peroxisomes is not dependent on factors from Kupffer cells and support the idea that stimulation of DNA synthesis and induction of peroxisomes occur via distinct mechanisms. Additionally, WY-14,643 increased liver mRNA transcripts of the hepatocyte mitogen tumor necrosis factor alpha (TNF alpha) more than twofold. This increase was also prevented by inactivating Kupffer cells with methyl palmitate. Therefore, it is concluded that Kupffer cells are causally responsible for WY-14,643-induced increases in hepatocyte DNA synthesis most likely by increasing production of TNF alpha, a hepatic mitogen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276615     DOI: 10.1093/carcin/18.8.1453

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.

Authors:  Jihan Youssef; Mostafa Badr
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 2.  Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

Authors:  Ivan Rusyn; Jeffrey M Peters; Michael L Cunningham
Journal:  Crit Rev Toxicol       Date:  2006-05       Impact factor: 5.635

3.  Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis.

Authors:  Qian Yang; Shinji Ito; Frank J Gonzalez
Journal:  Carcinogenesis       Date:  2007-02-28       Impact factor: 4.944

4.  Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.

Authors:  M R Hill; S Clarke; K Rodgers; B Thornhill; J M Peters; F J Gonzalez; J M Gimble
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats.

Authors:  Rodica Petruta Bunaciu; Job C Tharappel; Hans-Joachim Lehmler; Izabela Kania-Korwel; Larry W Robertson; Cidambi Srinivasan; Brett T Spear; Howard P Glauert
Journal:  Toxicology       Date:  2007-07-07       Impact factor: 4.221

Review 6.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

Review 7.  Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?

Authors:  R L Melnick
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

8.  Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: a role for Kupffer cells?

Authors:  Ibrahim A Alsarra; William G Brockmann; Michael L Cunningham; Mostafa Z Badr
Journal:  J Carcinog       Date:  2006-11-27

9.  Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.

Authors:  Eric Boitier; Jean-Charles Gautier; Ruth Roberts
Journal:  Comp Hepatol       Date:  2003-01-31

Review 10.  A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.

Authors:  Kathryn Z Guyton; Weihsueh A Chiu; Thomas F Bateson; Jennifer Jinot; Cheryl Siegel Scott; Rebecca C Brown; Jane C Caldwell
Journal:  Environ Health Perspect       Date:  2009-05-15       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.